Smashburger is pivoting toward a leaner seasonal strategy this summer, prioritizing operational simplicity to ensure consistency across its 178 locations. By reducing the number of limited-time offerings, the Denver-based chain aims to sharpen its focus on core product execution while maintaining the bold flavor profiles that define its brand identity.
The U.S. Environmental Protection Agency issued formal guidance on July 1, 2026, mandating that manufacturers provide independent repair shops and vehicle owners with essential emissions-related diagnostic tools and information. This directive reinforces federal support for the right to repair while explicitly citing industry-led collaboration as the standard for compliance.
IT teams can now generate custom automation scripts simply by describing technical issues in plain language, following the launch of Tia Scripting within TeamViewer’s Digital Employee Experience (DEX) platform. The tool removes the requirement for specialized coding expertise, allowing for rapid deployment of bespoke device management solutions.
With media budgets shifting heavily toward high-volume social video, most digital creative hits the market without consumer feedback due to speed and cost constraints. Zappi’s new Amplify AI platform aims to bridge this gap by using synthetic respondents to predict campaign performance before assets go live.
San Diego-based Kenai Therapeutics has finalized enrollment for its REPLACE Phase 1b/2a clinical trial, marking a pivotal moment in the testing of RNDP-001. This investigational cell therapy aims to address the root cause of idiopathic Parkinson’s disease by replacing lost dopaminergic neurons rather than merely managing symptoms.
With over 75% of pending wishes requiring travel, Make-A-Wish and Chase have renewed their partnership, pledging $3 million in Ultimate Rewards to bridge the funding gap. The collaboration, which has already facilitated 1,000 trips for children with critical illnesses, aims to offset rising travel costs during peak demand.
Saol Therapeutics has resubmitted its New Drug Application to the FDA for SL1009, a potential treatment for the rare mitochondrial disorder pyruvate dehydrogenase complex deficiency. The move follows months of regulatory dialogue that allowed the company to bypass new clinical trials in favor of supplemental survival analysis.
One year after the initial push for AI-enabled hiring, corporate talent acquisition has moved past experimentation into large-scale operational integration. New research from The Josh Bersin Company and AMS reveals that businesses are abandoning isolated tools in favor of unified architectures that prioritize long-term organizational capability over simple hiring speed.
Social Discovery Group has frozen payments to an affiliate partner and launched an external investigation following allegations of deceptive accounts on its platforms. The move comes as the dating conglomerate, which manages brands like Dating.com, attempts to curb a persistent industry-wide rise in romance-related fraud and misrepresentation.
Toronto-based Pathpal has secured a growth equity investment led by TA Group, marking a strategic push to scale its proactive grief-support platform. Alongside the funding, the company appointed Travis Allan as Managing Partner to spearhead an aggressive expansion across North America and prepare for future international growth.
The American Chemical Society has awarded Snapdragon Chemistry and NewAmsterdam Pharma the 2026 Green Chemistry Challenge Award for developing a sustainable synthetic pathway for obicetrapib. The breakthrough process replaces traditional manufacturing methods with an organocatalytic cyclization, drastically cutting waste and operational costs for the investigational dyslipidemia therapy.
By slashing process mass intensity by 80% and cutting manufacturing cycles by nearly three-quarters, Snapdragon Chemistry and NewAmsterdam Pharma have redefined efficiency in drug production. This breakthrough, focused on the synthesis of obicetrapib, earned the duo the American Chemical Society’s 2026 Green Chemistry Challenge Award.
Thousands of travelers descending on FIFA World Cup host cities are passing through checkpoints bolstered by artificial intelligence. SeeTrue, a security software developer, confirmed its prohibited item detection tool has earned TSA certification for integration with Analogic ConneCT scanners, marking a significant shift in airport screening automation.
A $1.3 million grant from the Maryland Energy Administration is backing a pilot program that integrates geothermal heating and cooling into 129 new homes. By utilizing a third-party leasing structure, developers Dream Finders Homes and Ward Communities aim to eliminate the upfront costs typically associated with high-efficiency HVAC installations.
Nearly one in five higher education submissions in the United States now shows significant AI involvement, doubling the usage rates observed in the United Kingdom and Australia. This sharp divide highlights a growing disparity in how students across different regions are integrating generative tools into their academic coursework.
Managing a fleet of 224,000 vehicles across North America requires more than logistics—it demands a unified digital ecosystem. Merchants Fleet has integrated the Super Dispatch platform to replace fragmented workflows, shifting its transportation management into a single, API-driven hub to track costs, carrier performance, and delivery timelines.
Boca Raton-based OZ Digital has integrated into the Anthropic Partner Network, positioning its consulting practice to deploy Claude-powered generative AI models directly through Microsoft Azure AI Foundry. The move aims to transition corporate clients from experimental AI projects to scalable, production-ready enterprise solutions.
Antimicrobial resistance poses an escalating threat to global healthcare, prompting Lakewood-Amedex Biotherapeutics to formally support the reintroduction of the PASTEUR Act. The Florida-based biotech firm argues that federal incentives for novel therapies are essential to address the rise of treatment-resistant pathogens like MRSA and VRE.
Most brands treat webinars as disposable live events, losing potential value the moment the stream ends. As marketing budgets tighten, platforms like Riverside are pushing a shift toward content infrastructure, where a single session serves as a foundational engine for social clips, newsletters, and long-term sales assets.
W. P. Carey Inc. will disclose its financial performance for the second quarter ending June 30, 2026, after the market closes on Tuesday, July 28. The New York-based net lease real estate investment trust plans to follow the release with a live conference call and audio webcast the following morning.
Chicago-based Paddletek Group has finalized the acquisition of performance paddle brand PIKKL while simultaneously securing four elite professional players. The move unites the technical expertise of PIKKL founders Mike Strommen and Dan Martinson with the competitive profile of siblings JW and Jorja Johnson, alongside Julie Johnson and Hurricane Tyra Black.
Full Circle Lithium Corp. is diving into the professional fishing circuit, securing a deal as the official Facebook Live sponsor for the Bassmaster Elite Series tournament on Lake Champlain. Running from August 13–16, the partnership aims to place the company’s fire-safety technology directly before millions of outdoor enthusiasts.
Baltimore-based Apkudo has introduced the Robotic Standalone Automation (RSA) appliance, the first system designed to handle the cosmetic and functional inspection of foldables, tablets, and flip phones without requiring hardware reconfiguration. Engineered by Alpha Automatics, the device aims to eliminate manual testing bottlenecks in the reverse logistics sector.
Salt Lake City-based employee engagement platform Awardco has earned a sweep of industry accolades in 2026, securing spots on lists from TIME, HR.com, and G2. The company’s recent growth highlights a strategic shift from simple recognition tools toward a unified, AI-powered solution for organizational culture.
Instagram’s recent crackdown on reposted content, which now extends to photos and carousels, has effectively ended the era of volume-based social media management. For agencies and teams juggling multiple accounts, the platform’s pivot toward original production requires a fundamental overhaul of how they maintain individual account credibility and growth.
New York-based private equity firm Regal Healthcare Capital Partners has closed its fourth fund at $610 million, exceeding its initial $550 million target. The firm, which focuses exclusively on healthcare services, secured the capital from a mix of existing partners and new institutional investors including pension plans and endowments.
Thirty years into a career that redefined hip-hop, Jay-Z is bringing his legacy to North London. The rapper confirmed a single UK date at Tottenham Hotspur Stadium on September 4, 2026, joining a limited run of stadium shows that already includes stops in Paris and Los Angeles.
Within the heart of Bengaluru’s primary technology corridor, DXC Technology has unveiled a sprawling 200,000-square-foot facility dedicated to scaling enterprise artificial intelligence. The center serves as a collaborative environment where engineers and clients aim to transition AI concepts into functional, large-scale deployments across global business operations.
Miami attorney and former federal prosecutor V. Michael Arias has officially qualified for the August 18, 2026, Republican primary. Seeking to unseat incumbent Representative Maria Elvira Salazar, Arias is positioning his four-decade career in law and financial regulation as the necessary antidote to stagnant leadership in Washington.
Dr. Sebastian Johnston will present clinical findings demonstrating that the investigational drug vapendavir reduces inflammatory biomarkers in COPD patients during the European Respiratory Society International Congress. The oral presentation, scheduled for September 9, 2026, highlights progress in treating rhinovirus-associated complications for those with chronic lung disease.
